vs

Side-by-side financial comparison of ALTISOURCE PORTFOLIO SOLUTIONS S.A. (ASPS) and Cronos Group Inc. (CRON). Click either name above to swap in a different company.

Cronos Group Inc. is the larger business by last-quarter revenue ($44.5M vs $42.3M, roughly 1.1× ALTISOURCE PORTFOLIO SOLUTIONS S.A.). Cronos Group Inc. runs the higher net margin — -4.1% vs -16.8%, a 12.8% gap on every dollar of revenue. On growth, Cronos Group Inc. posted the faster year-over-year revenue change (47.0% vs 3.2%). Cronos Group Inc. produced more free cash flow last quarter ($9.7M vs $-525.0K). Over the past eight quarters, Cronos Group Inc.'s revenue compounded faster (32.7% CAGR vs 3.6%).

Altisource Portfolio Solutions S.A. is a global provider of integrated technology, data and operational services for the mortgage, real estate and consumer finance sectors. It serves lenders, servicers and investors, offering solutions that streamline asset management and residential property transaction workflows to boost operational efficiency.

Cronos Group Inc. is a global cannabinoid firm specializing in cultivation, processing, and distribution of cannabis-derived products including wellness supplements, consumer goods, and medical cannabis. It serves North America, Europe, and Asia Pacific, catering to regulated recreational and medical consumer segments with quality-controlled offerings.

ASPS vs CRON — Head-to-Head

Bigger by revenue
CRON
CRON
1.1× larger
CRON
$44.5M
$42.3M
ASPS
Growing faster (revenue YoY)
CRON
CRON
+43.7% gap
CRON
47.0%
3.2%
ASPS
Higher net margin
CRON
CRON
12.8% more per $
CRON
-4.1%
-16.8%
ASPS
More free cash flow
CRON
CRON
$10.2M more FCF
CRON
$9.7M
$-525.0K
ASPS
Faster 2-yr revenue CAGR
CRON
CRON
Annualised
CRON
32.7%
3.6%
ASPS

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
ASPS
ASPS
CRON
CRON
Revenue
$42.3M
$44.5M
Net Profit
$-7.1M
$-1.8M
Gross Margin
26.5%
36.4%
Operating Margin
-15.5%
-16.8%
Net Margin
-16.8%
-4.1%
Revenue YoY
3.2%
47.0%
Net Profit YoY
18.2%
-104.2%
EPS (diluted)
$-1.02
$-0.01

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ASPS
ASPS
CRON
CRON
Q4 25
$42.3M
$44.5M
Q3 25
$41.9M
$36.3M
Q2 25
$43.3M
$33.5M
Q1 25
$43.4M
$32.3M
Q4 24
$41.0M
$30.3M
Q3 24
$40.5M
$34.3M
Q2 24
$39.1M
$27.8M
Q1 24
$39.5M
$25.3M
Net Profit
ASPS
ASPS
CRON
CRON
Q4 25
$-7.1M
$-1.8M
Q3 25
$-2.3M
$26.0M
Q2 25
$16.7M
$-39.7M
Q1 25
$-5.3M
$6.1M
Q4 24
$-8.7M
$43.7M
Q3 24
$-9.3M
$8.3M
Q2 24
$-8.3M
$-8.8M
Q1 24
$-9.2M
$-2.2M
Gross Margin
ASPS
ASPS
CRON
CRON
Q4 25
26.5%
36.4%
Q3 25
27.1%
50.4%
Q2 25
30.1%
43.4%
Q1 25
30.7%
42.6%
Q4 24
30.3%
35.7%
Q3 24
29.8%
10.5%
Q2 24
32.5%
22.7%
Q1 24
31.2%
17.7%
Operating Margin
ASPS
ASPS
CRON
CRON
Q4 25
-15.5%
-16.8%
Q3 25
1.2%
-1.4%
Q2 25
7.5%
-15.9%
Q1 25
7.5%
-12.6%
Q4 24
1.4%
-37.5%
Q3 24
2.7%
-98.2%
Q2 24
5.3%
-56.1%
Q1 24
-1.4%
-63.1%
Net Margin
ASPS
ASPS
CRON
CRON
Q4 25
-16.8%
-4.1%
Q3 25
-5.5%
71.4%
Q2 25
38.5%
-118.7%
Q1 25
-12.1%
19.0%
Q4 24
-21.3%
144.3%
Q3 24
-23.0%
24.4%
Q2 24
-21.1%
-31.5%
Q1 24
-23.2%
-8.9%
EPS (diluted)
ASPS
ASPS
CRON
CRON
Q4 25
$-1.02
$-0.01
Q3 25
$-0.22
$0.07
Q2 25
$1.48
$-0.10
Q1 25
$-0.09
$0.02
Q4 24
$-4.72
$0.12
Q3 24
$-2.61
$0.02
Q2 24
$-2.33
$-0.02
Q1 24
$-0.33
$-0.01

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ASPS
ASPS
CRON
CRON
Cash + ST InvestmentsLiquidity on hand
$26.6M
$831.8M
Total DebtLower is stronger
$191.1M
Stockholders' EquityBook value
$-110.2M
$1.1B
Total Assets
$139.8M
$1.2B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ASPS
ASPS
CRON
CRON
Q4 25
$26.6M
$831.8M
Q3 25
$28.6M
$824.2M
Q2 25
$30.0M
$834.4M
Q1 25
$30.8M
$837.8M
Q4 24
$29.8M
$858.8M
Q3 24
$28.3M
$862.0M
Q2 24
$29.7M
$848.2M
Q1 24
$29.6M
$855.1M
Total Debt
ASPS
ASPS
CRON
CRON
Q4 25
$191.1M
Q3 25
$192.5M
Q2 25
$193.9M
Q1 25
$195.0M
Q4 24
$230.5M
Q3 24
Q2 24
Q1 24
Stockholders' Equity
ASPS
ASPS
CRON
CRON
Q4 25
$-110.2M
$1.1B
Q3 25
$-104.2M
$1.1B
Q2 25
$-102.7M
$1.1B
Q1 25
$-119.8M
$1.1B
Q4 24
$-157.4M
$1.1B
Q3 24
$-149.4M
$1.1B
Q2 24
$-140.8M
$1.1B
Q1 24
$-133.3M
$1.1B
Total Assets
ASPS
ASPS
CRON
CRON
Q4 25
$139.8M
$1.2B
Q3 25
$139.9M
$1.2B
Q2 25
$142.9M
$1.2B
Q1 25
$145.7M
$1.2B
Q4 24
$143.6M
$1.2B
Q3 24
$144.5M
$1.2B
Q2 24
$146.6M
$1.1B
Q1 24
$148.9M
$1.1B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ASPS
ASPS
CRON
CRON
Operating Cash FlowLast quarter
$-505.0K
$11.8M
Free Cash FlowOCF − Capex
$-525.0K
$9.7M
FCF MarginFCF / Revenue
-1.2%
21.8%
Capex IntensityCapex / Revenue
0.0%
4.8%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-5.1M
$149.0K

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ASPS
ASPS
CRON
CRON
Q4 25
$-505.0K
$11.8M
Q3 25
$718.0K
$13.3M
Q2 25
$-306.0K
$2.8M
Q1 25
$-5.0M
$-2.1M
Q4 24
$-1.4M
$7.7M
Q3 24
$-1.6M
$11.6M
Q2 24
$180.0K
$1.7M
Q1 24
$-2.2M
$-2.2M
Free Cash Flow
ASPS
ASPS
CRON
CRON
Q4 25
$-525.0K
$9.7M
Q3 25
$697.0K
$8.8M
Q2 25
$-309.0K
$-1.0M
Q1 25
$-5.0M
$-17.4M
Q4 24
$-1.4M
$4.2M
Q3 24
$5.2M
Q2 24
$1.0M
Q1 24
$-3.9M
FCF Margin
ASPS
ASPS
CRON
CRON
Q4 25
-1.2%
21.8%
Q3 25
1.7%
24.3%
Q2 25
-0.7%
-3.0%
Q1 25
-11.5%
-53.8%
Q4 24
-3.4%
13.8%
Q3 24
15.1%
Q2 24
3.7%
Q1 24
-15.5%
Capex Intensity
ASPS
ASPS
CRON
CRON
Q4 25
0.0%
4.8%
Q3 25
0.1%
12.3%
Q2 25
0.0%
11.5%
Q1 25
0.1%
47.3%
Q4 24
0.0%
11.7%
Q3 24
0.0%
18.7%
Q2 24
0.0%
2.6%
Q1 24
0.0%
6.8%
Cash Conversion
ASPS
ASPS
CRON
CRON
Q4 25
Q3 25
0.51×
Q2 25
-0.02×
Q1 25
-0.34×
Q4 24
0.18×
Q3 24
1.39×
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ASPS
ASPS

Services$39.9M94%
Revenue Relatedto Technology Platformsand Professional Services$2.4M6%

CRON
CRON

Cannabis Flower$33.7M76%
Cannabis Extracts$10.8M24%

Related Comparisons